type here...

CATEGORIES

Press Release

LATEST

1...789...12Page 8 of 12

TRENDING

EDITORS CHOICE

First “Global State of Digital Health Report” Tapping into 200 Million Data Points Examines More Than 12,000 Digital Health Ventures Now Available

Medika Life -
Breaking Digital Health Report Will Guide C-Suite Entrepreneurs and Private Equity Investment Strategies

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

Medika Life -
INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Never-Before-Seen COVID-19 Data Report Released by HHS

Medika Life -
HHS has just released the "COVID Community Profile Report," a daily updated snapshot of how COVID-19 is affecting our states and communities

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories